Article Information
vol. 21 no. 125 218-222
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 20, 2012
- Accepted June 6, 2012
- Published online August 31, 2012.
Copyright & Usage
©ERS 2012
Author Information
- *Centre for Lung Health, Mater Misericordiae University Hospital, Dublin, Ireland. #Université Paris-Sud 11, Faculté de Médecine, ¶Service de Pneumologie et Réanimation Respiratoire, Hôpital Bicêtre, AP-HP, Centre National de Référence de l'Hypertension Pulmonaire Sévère, Le Kremlin-Bicêtre, and +INSERM U999, Hypertension Artérielle Pulmonaire, Physiopathologie et Innovation Thérapeutique, Le Plessis-Robinson, France.
- M. Humbert, Service de Pneumologie, Hôpital Bicêtre, 78 rue du Général Leclerc, 94270 Le Kremlin-Bicêtre, France. E-mail: marc.humbert{at}bct.aphp.fr
Article usage
Altmetrics
Vol 21 Issue 125
Table of Contents
A critical analysis of survival in pulmonary arterial hypertension
Jump To
- Article
- Abstract
- THE EPIDEMIOLOGY OF PAH IN FRANCE
- NATURAL HISTORY OF IPAH ACCORDING TO THE US NATIONAL INSTITUTES OF HEALTH REGISTRY
- IMPROVED OUTCOMES OF IPAH PATIENTS IN THE MODERN TARGETED THERAPY ERA: SURVIVAL DATA IN COHORTS TREATED BY i.v. EPOPROSTENOL
- IPAH SURVIVAL AND TARGETED THERAPY: EVIDENCE FROM RANDOMISED CONTROLLED TRIALS
- THE FRENCH PAH REGISTRY
- DEVELOPMENT OF OTHER PROGNOSTIC EQUATIONS TO ESTIMATE OUTCOMES IN PAH PATIENTS: THE CHICAGO, SCOTTISH AND REVEAL EXPERIENCES
- CONCLUSION
- Footnotes
- REFERENCES
- Info & Metrics